Revenues Grew 740%+ in 2025 and Targets $4 Billion in Annualized Processing Volume in 2026

2025年收入增长740%以上，目标是2026年实现40亿美元的年化处理量。

***

***

CityMD Founder Dr. Richard Park joins Board

CityMD创始人理查德·帕克博士加入董事会

***

***

Watch the founder video and blog post

观看创始人视频和博客文章

NEW YORK

纽约

,

，

March 10, 2026

2026年3月10日

/PRNewswire/ --

/PRNewswire/ --

Nitra

尼特拉

, the leading AI-native, all-in-one operating platform for healthcare practices and their back offices, today announced $187 million in financing across its Series A and Series B rounds, venture debt, and warehouse facility, bringing the company's total capital raised to $205 million and total equity raised to $90 million..

，领先的AI原生、一体化医疗实践及其后台办公操作系统平台，今天宣布在A轮和B轮融资、风险债务及仓储设施中筹集了1.87亿美元，使公司总融资额达到2.05亿美元，股权融资总额达到9000万美元。

Continue Reading

继续阅读

(Tim Hwang, left, with Jonathan Chen)

（左为蒂姆·黄，与乔纳森·陈在一起）

The funding follows a breakout year for Nitra, which grew revenues 740%+ in 2025, surpassing $1 billion in annualized processing volume as healthcare practices increasingly expand uses of AI beyond clinical decision support and scribing into administration, finances and inventory, and the back office..

这笔资金是在Nitra实现突破性增长的一年后获得的，该公司在2025年的收入增长了740%以上，年度处理量超过10亿美元。随着医疗机构越来越多地将人工智能的用途从临床决策支持和记录扩展到管理、财务、库存以及后台办公，Nitra实现了这一里程碑。

The financing includes $72 million of new equity across a $50 million Series B round and a previously unannounced $22 million Series A completed in August 2025 from investors including Actions Capital, AppWorks, Comma Capital, Dunamu & Partners, Era Funds, New Enterprise Associates (NEA), Pantera Capital, and Sazze Partners..

融资包括 7200 万美元的新股权，其中包含 5000 万美元的 B 轮融资和 2025 年 8 月完成的、之前未公布的 2200 万美元 A 轮融资，投资者包括 Actions Capital、AppWorks、Comma Capital、Dunamu & Partners、Era Funds、New Enterprise Associates (NEA)、Pantera Capital 和 Sazze Partners。

The financing also included participation from AAF, Gaingels, Hyphen Capital, K8, Mana Ventures, Necessary Ventures, PIDC/Uni-President, Purestone Silks, SignalRank, Simu Liu's Markham Valley Ventures, Soma Capital, and others.

本轮融资还吸引了来自AAF、Gaingels、Hyphen Capital、K8、Mana Ventures、Necessary Ventures、PIDC/统一、Purestone Silks、SignalRank、刘思慕的Markham Valley Ventures、Soma Capital等公司的参与。

The company also secured $20 million in venture debt from Avenue Capital Group and an expanded $95 million warehouse facility from Treville Capital Group and Encina Lender Finance, LLC.

该公司还从Avenue Capital Group获得了2000万美元的风险债务，并从Treville Capital Group和Encina Lender Finance, LLC获得了9500万美元的扩展仓储设施。

Dr. Richard Park, founder and former CEO of CityMD, joined Nitra's Board of Directors. CityMD merged with Summit Health, and the combined company was acquired by VillageMD (owned by Walgreens) for $8.9 billion in 2023. Today, Dr. Park oversees Ascend Partners as the co-founder and Managing Partner. His appointment adds deep operational healthcare experience as the company scales its platform..

理查德·帕克博士，CityMD的创始人兼前首席执行官，加入了Nitra的董事会。CityMD与Summit Health合并后，这家合并后的公司于2023年被沃尔格林旗下的VillageMD以89亿美元收购。如今，帕克博士作为联合创始人兼管理合伙人，负责监管Ascend Partners。他在公司扩展平台的过程中带来了深厚的医疗运营经验。

Healthcare is a nearly $5.9 trillion industry in the United States, yet an estimated 25% of spending goes toward administrative costs. Medical practices still rely on fragmented systems for payments, procurement, inventory, scheduling, and insurance verification.

美国的医疗保健行业规模接近5.9万亿美元，但据估计有25%的支出用于行政成本。医疗机构在支付、采购、库存、日程安排和保险验证等方面仍然依赖分散的系统。

Launched in 2024 by Tim Hwang (CEO) and Jonathan Chen (President), Nitra's platform embeds AI agents directly into the operational backbone of practices. Nitra gives physicians, who are overwhelmed by administrative overload, complete control over their back office and administrative functions. Nitra's .

2024年由蒂姆·黄（首席执行官）和乔纳森·陈（总裁）推出的Nitra平台，将人工智能代理直接嵌入到医疗机构的运营骨干中。Nitra使那些因行政负担过重而感到不堪重负的医生能够完全掌控他们的后台办公和行政职能。

all-in-one

一体化

platform for healthcare practices now includes:

医疗实践平台现在包括：

Financial Automation,

金融自动化，

offering a Visa-powered expense card, expense management, bill pay, patient payment processing, and AI agents for healthcare accounting automation;

提供由Visa支持的支出卡、费用管理、账单支付、患者支付处理以及用于医疗会计自动化的AI代理；

Commerce and Inventory

商业与库存

, providing direct access to tens of thousands of biopharmaceuticals and medical equipment products in partnership with firms like McKesson and Medline. Nitra's AI procurement agents handle suppliers, negotiate prices, onboard vendors, execute purchases, and monitor inventory end-to-end, and

，与麦凯森和美迪莱等公司合作，直接提供数万种生物制药和医疗设备产品。Nitra的AI采购代理负责处理供应商、谈判价格、引入供应商、执行采购并全程监控库存，而且

Patient Management

病人管理

, launched this month, powers voice AI agents for patient scheduling and insurance eligibility checks. The system integrates scheduling, benefits verification, and patient communication into the broader operational stack, reducing administrative burden for healthcare practices.

，于本月推出，为患者预约和保险资格检查提供语音AI代理支持。该系统将预约、福利验证和患者沟通整合到更广泛的运营体系中，减轻了医疗机构的行政负担。

In 2025, the company grew by over 740% from $4 million of annualized revenues to over $33 million in a single year. This growth was powered by a platform that is now used by thousands of doctors in over 700 clinics and processed over $1 billion in annualized volumes across its platform. In December of 2025, Nitra supported upwards of $9 million in high-stakes, patient-critical biopharma and medical purchases for physicians in a single day..

2025年，公司年收入从400万美元增长到超过3300万美元，增幅超过740%。这一增长得益于一个平台的推动，该平台现已被700多家诊所的数千名医生使用，并在其平台上处理了超过10亿美元的年化交易量。2025年12月，Nitra在一天内支持了高达900万美元的高风险、对患者至关重要的生物制药和医疗采购。

The company is on track to cross over 3,000 clinics, more than $150 million of annualized revenues, and over $4 billion in annualized processing volumes in 2026. As part of its growth, the company has announced that headcount is expected to grow from 50 people last year to over 200 by the end of 2026 and plans to launch additional AI modules in revenue cycle management, patient marketing, and payroll/staffing.

到2026年，该公司有望突破3000家诊所、超过1.5亿美元的年收入以及超过40亿美元的年处理量。作为增长的一部分，公司宣布员工人数预计将从去年的50人增加到2026年底的200人以上，并计划在收入周期管理、患者营销以及薪资/人员配置方面推出更多人工智能模块。

With this raise, Nitra plans to accelerate AI development, expand its engineering team, and scale its operating system across thousands of healthcare practices nationwide..

通过这次融资，Nitra 计划加速人工智能开发，扩大其工程团队，并在全国范围内数千家医疗机构中推广其操作系统。

'We're on a mission to serve the people that serve our communities and help doctors save time and money,' said Tim Hwang. 'Practices are running critical workflows across disconnected systems that were never designed to work together. Nitra brings those layers together into a single AI-native operating system that helps healthcare practices run their operations more efficiently.'.

“我们致力于服务那些为我们的社区服务的人，并帮助医生节省时间和金钱，”蒂姆·黄说。“医疗机构的运作流程分散在互不相连的系统中，而这些系统从未被设计成协同工作。Nitra将这些层面整合到一个单一的原生人工智能操作系统中，帮助医疗机构更高效地运行其操作。”

Nitra has attracted some of the most prominent healthcare practices in the country, such as Bay Area Retina Associates, Southern Vitreoretinal Associates (SVA), Elase Medspa, PhyNet Dermatology, Brandywine Urology, and Empower Aesthetics.

尼特拉吸引了一些美国最著名的医疗实践机构，如湾区视网膜协会、南维特视网膜协会（SVA）、艾拉塞医学水疗中心、菲尼特皮肤科、白兰地酒泌尿科和赋能美学。

'Nitra is creating a new category of platform for healthcare practices,' said

“Nitra正在为医疗实践创建一个全新的平台类别，”表示

Adarsh Bhatt, General Partner at Comma Capital.

阿达尔什·巴特，康玛资本的普通合伙人。

'From the beginning, we viewed the

‘从一开始，我们就认为

fintech

金融科技

entry point as the wedge into a much larger opportunity to build the AI-native operating platform for healthcare providers. Since our seed investment, the Nitra team has consistently executed on that vision. As someone who regularly speaks with clinicians and practice owners, it's clear there is a strong demand for modern financial and operational infrastructure purpose-built for healthcare practices.

切入点是构建面向医疗保健提供商的原生人工智能操作平台的更大机遇的楔子。自从我们种子轮投资以来，Nitra团队一直在坚定地执行这一愿景。作为一名经常与临床医生和诊所所有者交流的人，很明显，市场对专为医疗机构打造的现代化财务和运营基础设施有着强烈的需求。

This round positions Nitra to deepen that platform and expand the capabilities providers rely on every day.'.

这一轮定位使 Nitra 能够深化该平台，并扩展提供商每天依赖的功能。

'Providing $20 million in venture debt reflects our conviction in the Nitra team and the company's momentum,' said Dan Holman, Senior Portfolio Manager for Avenue Capital Group's Growth Lending Strategy. 'Tim Hwang and Jonathan Chen are exceptional founders with a strong track record of building and scaling ambitious platforms, and we believe Nitra is well positioned to become critical infrastructure for healthcare practices.'.

“提供2000万美元的风险债务反映了我们对Nitra团队和公司发展势头的信心，”Avenue Capital Group增长借贷策略的高级投资组合经理Dan Holman表示。“Tim Hwang和Jonathan Chen是杰出的创始人，拥有构建和扩展雄心勃勃平台的良好记录，我们相信Nitra有能力成为医疗实践的关键基础设施。”

Nitra previously raised its Seed round in 2022 from investors including Andreessen Horowitz, NEA, Pantera, KB Financial Group, Jerry Yang/AME Cloud Ventures, Gold House Ventures, Primer Sazze, Will Smith and Keisuke Honda's Dreamers VC, Sparklabs, Expa, Era, Comma Capital, Dunamu and Partners, etc. and others..

Nitra 于 2022 年从包括 Andreessen Horowitz、NEA、Pantera、KB Financial Group、Jerry Yang/AME Cloud Ventures、Gold House Ventures、Primer Sazze、Will Smith 和 Keisuke Honda 的 Dreamers VC、Sparklabs、Expa、Era、Comma Capital、Dunamu and Partners 等投资者那里完成了种子轮融资。

About Nitra

关于尼特拉

Nitra is an AI-native operating system for healthcare practices to run their business and back office. The platform spans finance, procurement, a medical supplies marketplace and patient administration, automating workflows like payments, purchasing, inventory, scheduling, insurance verification, and patient communication.

Nitra 是一个专为医疗机构打造的原生人工智能操作系统，用于运营业务和后台办公。该平台涵盖财务、采购、医疗用品市场及患者管理，可自动处理支付、采购、库存、排程、保险验证和患者沟通等工作流程。

By embedding AI directly into its infrastructure, Nitra unifies these functions into a single system, reducing manual administrative work and improving operational visibility..

通过将人工智能直接嵌入其基础设施，Nitra 将这些功能整合到一个系统中，减少了手动管理工作并提高了运营可见性。

Media Contact

媒体联系人

Jessica Ortiz, VP

杰西卡·奥尔蒂斯，副总裁

Ditto PR

Ditto 公关

[email protected]

电子邮件地址

SOURCE Nitra

源代码 Nitra

21

21

%

%

more press release views with

更多新闻发布观点

Request a Demo

请求演示